Results 51 to 60 of about 3,281 (193)

Role of microbiota in pain: From bench to bedside

open access: yesiMetaOmics, Volume 2, Issue 1, March 2025.
Pain is closely linked to microbes. The microbiota modulates pain perception through three mechanisms: microbiota‐derived metabolites, immunoregulation, and direct stimulation on neurons. Therapeutic strategies like probiotics, fecal microbiota transplantation, and dietary changes show significant potential in pain management.
Huiguang Ren   +5 more
wiley   +1 more source

Integrated Analysis of Vonoprazan Safety for Symptomatic Gastro‐Oesophageal Reflux Disease or Erosive Oesophagitis

open access: yesAlimentary Pharmacology &Therapeutics, Volume 61, Issue 5, Page 835-851, March 2025.
The safety of vonoprazan was evaluated in an integrated analysis of data from clinical trials and post‐marketing experience in adults with symptomatic gastro‐oesophageal reflux disease or erosive oesophagitis. Vonoprazan was well tolerated, with a similar safety profile to proton pump inhibitor comparators.
Colin W. Howden   +8 more
wiley   +1 more source

Towards microbiome transplant as a therapy for periodontitis: an exploratory study of periodontitis microbial signature contrasted by oral health, caries and edentulism [PDF]

open access: yes, 2015
published_or_final_versio
Alex E. Pozhitkov   +5 more
core   +2 more sources

Harnessing the gut microbiome to enhance cancer immunotherapy: Current advances and future directions in microbiota‐based therapeutic strategies

open access: yesMedComm – Future Medicine, Volume 3, Issue 4, December 2024.
Multiple roles of gut microbiota in tumor immunotherapy. Gut microbiota plays a crucial role in programming innate and acquired immune responses, often affecting immunotherapy efficacy. They serve as biomarkers of efficacy and prognosis, and provide insights into microbiota‐based therapeutic strategies.
Binyan Zhao   +5 more
wiley   +1 more source

Microbes as medicine

open access: yesAnnals of the New York Academy of Sciences, Volume 1541, Issue 1, Page 63-82, November 2024.
The explosion of research into the human microbiome has revealed the many ways in which our microbes enhance our health. Could these host‐associated microbes be exploited as novel therapies to treat disease? In this review, the various strategies for using microbes as medicine that have been thus far employed, as well as the potential new treatments of
Brendan A. Daisley, Emma Allen‐Vercoe
wiley   +1 more source

An Atypical Presentation of Crohn Disease in the Elderly. A Case report and Literature review [PDF]

open access: yes, 2003
The Authors present a case of an insidious onset of Crohn Disease (CD) in an elderly patient. Diagnosis complicated by extraintestinal manifestation properly of old age could be delayed and often made after surgery on the histological specimen as in ...
Mattia,, S.   +5 more
core  

Intestinal Microbiota, Probiotics and Mental Health: From Metchnikoff to Modern Advances: Part I – Autointoxication Revisited [PDF]

open access: yes, 2013
Mental health disorders, depression in particular, have been described as a global epidemic. Research suggests that a variety of lifestyle and environmental changes may be driving at least some portion of the increased prevalence. One area of flourishing
Bested, Alison C   +2 more
core   +1 more source

The Role of Microbiome and Probiotics in Chemo‐Radiotherapy‐Induced Diarrhea: A Narrative Review of the Current Evidence

open access: yesCancer Reports, Volume 7, Issue 10, October 2024.
ABSTRACT Background In this article, we review the most recent research on probiotics effects on diarrhea in both human and animal models of the condition along with the therapeutic potential of these compounds based on their findings. Recent Findings Nearly 50%–80% of cancer patients experience chemotherapy‐induced diarrhea (CID), serious ...
Sanaz Khorashadizadeh   +4 more
wiley   +1 more source

Enhancing cancer immunotherapy and antiangiogenic therapy by regulating gut microbes: Opportunities and challenges

open access: yesMedComm – Oncology, Volume 3, Issue 3, September 2024.
Immune checkpoint therapy is the main means of cancer treatment. However, most patients develop strong resistance to it. Another cancer treatment is antiangiogenic therapy. It enhances tumor immune response. Gut microbes enhance the efficacy of immunotherapy. We hope that the three of them will be able to treat cancer together.
Jie Xu   +4 more
wiley   +1 more source

Rifampin-induced Pseudomembranous Colitis with Rectosigmoid Sparing [PDF]

open access: yes, 2011
Pseudomembranous colitis (PMC) is known to be associated with antibiotic treatment, but is not commonly related to antitubercular (anti-TB) agent, rifampin.
Akbar   +17 more
core   +2 more sources

Home - About - Disclaimer - Privacy